Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients (original) (raw)
Dvorak CC, Steinbach WJ, Brown JMY, Agarwal R . Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2005; 36: 621–629. ArticleCASPubMed Google Scholar
Kobayashi R, Kaneda M, Sato T, Suzuki D, Ichikawa M, Ariga T . Evaluation of risk factors for invasive fungal infection after allogeneic stem cell transplantation in pediatric patients. J Pediatr Hematol Oncol 2007; 29: 786–791. ArticlePubMed Google Scholar
Kobayashi R, Kaneda M, Sato T, Ichikawa M, Suzuki D, Ariga T . The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan. J Pediatr Hematol Oncol 2008; 30: 886–890. ArticlePubMed Google Scholar
Hovi L, Saarinen-Pihkala UM, Vettenranta K, Saxen H . Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 2000; 26: 999–1004. ArticleCASPubMed Google Scholar
Benjamin DK Jr, Miller WC, Bayliff S, Martel L, Alexander KA, Martin PL . Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J 2002; 21: 227–234. ArticlePubMed Google Scholar
Crassard N, Hadden H, Pondarre C, Hadden R, Galambrun C, Piens MA et al. Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience. Transpl Infect Dis 2008; 10: 177–183. ArticleCASPubMed Google Scholar
Mikulska M, Raiola AM, Bruno B, Furfaro E, Van Lint MT, Bregante S et al. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant 2009; 44: 361–370. ArticleCASPubMed Google Scholar
Srinivasan A, Wang C, Srivastava DK, Burnette K, Shenep JL, Leung W et al. Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2012 pii S1083-8791: 00334–00335. Google Scholar
Marr KA, Carter RA, Crippa F, Wald A, Corey L . Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909–917. ArticlePubMed Google Scholar
Barnes PD, Risks Marr KA . Diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol 2007; 139: 519–531. ArticlePubMed Google Scholar
Castagnola E, Faraci M, Moroni C, Bandettini R, Granata C, Caruso S et al. Invasive mycoses in children receiving hemopoietic SCT. Bone Marrow Transplant 2008; 41: S107–S111. ArticlePubMed Google Scholar
Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010 1550: 1091–1100. ArticlePubMed Google Scholar
Kontoyiannis DP . Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success. Bone Marrow Transplant 2011; 46: 165–173. ArticleCASPubMed Google Scholar
Rogers TR, Slavin MA, Donnelly JP . Antifungal prophylaxis during treatment for haematological malignancies: are we there yet? Br J Haematol 2011; 153: 681–697. ArticlePubMed Google Scholar
Pauw de BE . What are fungal infections? Mediterr J Hematol Infect Dis 2011; 3: e2011001. Article Google Scholar
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304. ArticleCASPubMed Google Scholar
Pauw DeB, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from European organisation for research and treatment of cancer/invasive fungal infections cooperative Group and the national institute of allergy and infectious diseases mycoses study Group (EORTC/MSG) concensus Group. Clin Infect Dis 2008; 46: 1813–1821. ArticlePubMed Google Scholar
Blyth CC, Hale K, Palasanthiran P, O'Brien T, Bennett MH . Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections. Cochrane Database Syst Rev 2010; 17 CD006343.
Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 2008; 5: e219. ArticlePubMedPubMed Central Google Scholar
Bartelink IH, Wolfs T, Martine J, de Waal M, Egberts TC, Ververs TT et al. Immune reconstitution kinetics as an early predictor for mortality using various hematopoietic stem cell sources in children. Biol Blood Marrow Transplant 2012 22. pii S1083-8791: 00426–0. Google Scholar
Ram R, Gafter-Gvili A, Yeshurun M, Paul M, Raanani P, Shpilberg O . Prophylaxis regimens for GVHD: systematic review and meta-analysis. Bone Marrow Transplant 2009; 43: 643–653. ArticleCASPubMed Google Scholar
Rocha V, Locatelli F . Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 2008; 41: 207–214. ArticleCASPubMed Google Scholar